CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Paediatric Stroke
University of California, San FranciscoSmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Paediatric Stroke cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS University of California, San Francisco | Phase 4 | BB |
Sonovue Turku University Hospital | Phase 3 | B |
Darbepoetin Alfa UMC Utrecht | Phase 2 | CCC |
AUTOLOGOUS UMBILICAL CORD BLOOD James Baumgartner, MD | Phase 1/2 | CC |
Autologous Human Cord Blood Derived Stem Cell Aryn Knight | Phase 1 | CC |
Same molecule, other indications
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →